Gruber James R. 4
4 · Eton Pharmaceuticals, Inc. · Filed Aug 20, 2025
Insider Transaction Report
Form 4
Gruber James R.
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-08-20$16.02/sh−2,631$42,149→ 204,753 total - Sale
Common Stock
2025-08-19$16.16/sh−39,082$631,565→ 205,299 total
Footnotes (3)
- [F1]The shares were sold in multiple trades at prices ranging from $16.01 to $16.43. The price reported above reflects the weighted average sales price.
- [F2]The shares were sold in multiple trades at prices ranging from $15.90 to $16.19. The price reported above reflects the weighted average sales price.
- [F3]The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.